A clinical trial of CTX-471 in patients with various solid tumors
Phase of Trial: Phase I
Latest Information Update: 03 Jan 2019
At a glance
- Drugs CTX-471 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 03 Jan 2019 According to a Compass Therapeutics media release, the drug is expected to enter the clinic in the first quarter of 2019.
- 18 Jul 2018 New trial record
- 12 Jul 2018 According to a Compass Therapeutics media release, this trial is expected to start in the first half of 2019.